Version history
1 version on record. Newest first; the live version sits at the top with a live indicator.
- Live5/17/2026, 4:35:28 PM
636c22ed403bContent snapshot
{ "kind": "infographic", "prompt": "Drug-Specific Mechanisms: Challenging the Final Common Pathway figure 3", "provider": "other", "raw_fields": { "papers": [ { "n": null, "doi": "10.1038/s41586-025-09427-8", "value": null, "method": "various", "metric": "reward circuit engagement", "cite_key": "Gomez2025", "n_analyzed": null, "text_access": "fulltext", "n_definition": "animals or subjects", "scope_region": "mesolimbic circuit", "study_system": "rats", "taxonomic_level": "drug class", "scope_population": "drug-exposed", "value_source_sentence": null, "experimental_conditions": "Expression of an excitatory cocaine-gated channel in the rat lateral habenula, a brain region that i" }, { "n": 6, "doi": "10.3389/fphar.2026.1757023", "value": "1%", "method": "various", "metric": "reward circuit engagement", "cite_key": "deOliveira2026", "n_analyzed": 6, "text_access": "fulltext", "n_definition": "animals or subjects", "scope_region": "mesolimbic circuit", "study_system": "mice", "taxonomic_level": "drug class", "scope_population": "drug-exposed", "value_source_sentence": "2.2 Drugs The animals were treated with FK506 (Tacrolimus; LC Laboratory, United States), which was diluted in a solution of 1% DMSO, 5% Tween 80, and sterile saline, at a dose of 5 mg/kg, administered via subcutaneous (s.c.) injection 80 min before each behavioral test.", "experimental_conditions": "Dendritic spine density was evaluated in the dentate gyrus and nucleus accumbens.<h4>Results</h4>In " }, { "n": null, "doi": "10.7554/elife.100085", "value": "25%", "method": "various", "metric": "reward circuit engagement", "cite_key": "Oriol2025", "n_analyzed": null, "text_access": "fulltext", "n_definition": "animals or subjects", "scope_region": "mesolimbic circuit", "study_system": "rats", "taxonomic_level": "drug class", "scope_population": "drug-exposed", "value_source_sentence": "Glutamate neurons are also prevalent in VTA and overlap with other populations such that ~25% of VTA glutamate neurons co-express a DA marker and ~25% express a GABA marker ( Conrad et al., 2024 ; Ma et al., 2023 ; Phillips et al., 2022 ).", "experimental_conditions": "Challenging previous assumptions, we found that VTA neurons genetically defined by expression of par" }, { "n": null, "doi": "10.1038/s42003-026-09705-9", "value": "3.8%", "method": "various", "metric": "reward circuit engagement", "cite_key": "Zhang2026b", "n_analyzed": null, "text_access": "fulltext", "n_definition": "animals or subjects", "scope_region": "mesolimbic circuit", "study_system": "rats", "taxonomic_level": "drug class", "scope_population": "drug-exposed", "value_source_sentence": "Cannabis and depression Approximately 3.8% of the global population has used cannabis, primarily due to cannabinoids, which are classified as endocannabinoids, phytocannabinoids, and synthetic cannabinoids.", "experimental_conditions": "Emerging evidence indicates that chronic exposure to addictive substances can induce or exacerbate d" } ], "comparison_id": "fig_sec5_convergent_vs_divergent", "comparison_type": "evidence_scorecard", "homogeneity_check": { "caveats": [ "Evidence strength varies by drug class — some have decades of research, others are newer", "DA-dependent vs DA-independent evidence is asymmetric across drugs", "Self-administration paradigms differ across drug classes" ], "comparable": true, "n_definition": "studies reporting DA measurement", "scope_region": "nucleus accumbens and related regions", "taxonomic_level": "drug class", "scope_population": "drug-exposed rodents or humans" }, "suggested_plot_type": "heatmap" }, "section_id": "section_05_evidence", "source_url": "https://github.com/AllenNeuralDynamics/ComputationalReviewAddiction/blob/43d33061a22aa4fed3f7dc71fabbfa48ab1d6f48/evidence/section_05_evidence.json", "target_ref": "wiki_page:computationalreviewaddiction-05", "review_repo": "ComputationalReviewAddiction", "section_ref": "wiki_page:computationalreviewaddiction-05", "source_path": "evidence/section_05_evidence.json", "source_refs": [ "paper:paper-a77b6ea3644a", "paper:paper-b41cb09f704f", "paper:paper-b7c11c558bcb", "paper:paper-d32f13914759" ], "section_title": "Drug-Specific Mechanisms: Challenging the Final Common Pathway", "source_policy": { "mode": "public_source_pointer_with_short_context", "notes": [ "Local review repositories are read-only inputs.", "SciDEX stores paper metadata, structured evidence, file pointers, and short citation contexts; it does not copy full review prose." ], "source_commit_sha": "43d33061a22aa4fed3f7dc71fabbfa48ab1d6f48", "source_repository_url": "https://github.com/AllenNeuralDynamics/ComputationalReviewAddiction" }, "generation_status": "complete", "review_bundle_ref": "analysis_bundle:ab-d95cfb705572", "origin_url": "https://github.com/AllenNeuralDynamics/ComputationalReviewAddiction/blob/43d33061a22aa4fed3f7dc71fabbfa48ab1d6f48/evidence/section_05_evidence.json", "commit_sha": "43d33061a22aa4fed3f7dc71fabbfa48ab1d6f48", "created_by": "persona-jerome-lecoq-gbo-neuroscience", "repository_url": "https://github.com/AllenNeuralDynamics/ComputationalReviewAddiction" }